Authors:
Blondeau, JM
Vaughan, D
Laskowski, R
Borsos, S
Citation: Jm. Blondeau et al., Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents, INT J ANT A, 17(6), 2001, pp. 457-464
Citation: D. Vaughan, More about Tudor (Response to Leo Kersley's letter about the Royal-Ballet programme notes), DANCING TIM, 91(1088), 2001, pp. 696-696
Authors:
Dzau, VJ
Bernstein, K
Celermajer, D
Cohen, J
Dahlof, B
Deanfield, J
Diex, J
Drexler, H
Ferrari, R
van Gilst, W
Hansson, L
Hornig, B
Husain, A
Johnston, C
Lazar, H
Pepine, C
Rabelink, T
Remme, W
Ruilope, L
Ruzicka, M
Schunkert, H
Swedberg, K
Unger, T
Vaughan, D
Weber, M
Citation: Vj. Dzau et al., The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data, AM J CARD, 88(9A), 2001, pp. 1L-20L
Citation: Jm. Blondeau et D. Vaughan, In vitro activity of 19 antimicrobial agents against 3513 nosocomial pathogens collected from 48 Canadian medical centres, INT J ANT A, 15(3), 2000, pp. 213-219
Authors:
Guillen, C
McInnes, IB
Vaughan, D
Speekenbrink, ABJ
Brock, JH
Citation: C. Guillen et al., The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis, ARTH RHEUM, 43(9), 2000, pp. 2073-2080
Authors:
Torrance, G
Walker, V
Grossman, R
Mukherjee, J
Vaughan, D
La Forge, J
Lampron, N
Citation: G. Torrance et al., Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 Year, PHARMACOECO, 16(5), 1999, pp. 499-520